Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
70 participants
INTERVENTIONAL
2011-08-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reduction of Microemboli of Air Using a New Developed Air Trap (EmbolessTM) During Haemodialysis
NCT06168539
Confirmatory Study to Assess the V Needle in End-Stage Renal Disease Patients During In-Clinic Hemodialysis
NCT05493423
VectorFlow Tunneled Dialysis Catheter (TDC) Versus Palindrome TDC
NCT02685995
Three-dimensional (3D) Printed Hemodialysis Vascular Model
NCT05096416
A Comparative Study of Two Kinds of Hemodialysis Filters
NCT05899283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
New venous needle, the "BME needle"
Hemodialysis using the new venous needle, the "BME needle".
Hemodialysis using a new venous needle, the "BME needle"
Hemodialysis using a new venous dialysis needle or the "BME needle"
Hemodialysis using a new venous needle, the "BME needle"
One hemodialysis using a new venous needle, the "BME needle"
Standard venous needle, the "standard needle"
One hemodialysis using the standard venous needle, the "standard needle" (device).
Hemodialysis using the standard venous needle
Hemodialysis using the standard venous dialysis needle
Hemodialysis using the standard venous needle
One hemodialysis using the standard venous needle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemodialysis using the standard venous needle
Hemodialysis using the standard venous dialysis needle
Hemodialysis using a new venous needle, the "BME needle"
Hemodialysis using a new venous dialysis needle or the "BME needle"
Hemodialysis using a new venous needle, the "BME needle"
One hemodialysis using a new venous needle, the "BME needle"
Hemodialysis using the standard venous needle
One hemodialysis using the standard venous needle
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria:patients with fever, infection, inflammation or malignancy will be excluded
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Biomedical Enterprises Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Biomedical Enterprises Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alfredo R Zarate, MD
Role: PRINCIPAL_INVESTIGATOR
Biomedical Enterprises Inc
Pedro A Jose, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Children National Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
DaVita K Street Dialysis Center
Washington D.C., District of Columbia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BME-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.